Sanofi (EPA: SASY) has announced encouraging late-stage clinical trial results for its investigational drug amlitelimab, ...

ATLANTIS is a phase 2 global, single-arm, open-label, long-term safety study of amlitelimab for the treatment of patients 12 years or older with moderate to severe atopic dermatitis (AD) with a ...

Californian biopharma Corvus Pharmaceuticals has announced positive results from cohort four of the randomized, blinded, ...

Nearly 9 in 10 adults and parents of children with plaque psoriasis, atopic dermatitis, and seborrheic dermatitis being ...

A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new study says. Nemolizumab (Nemluvio) relieved itchiness within two days for three ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Kymera Therapeutics reported on Monday that, for the second time this year, it has ...

Patients with eczema say they receive conflicting medical advice when it comes to how often they can take a shower or bath. A new study offers some reassuring findings. A recent four-week study found ...

A major study has found that people with eczema are able to bathe either daily or weekly, without any impact to their symptoms. The findings of the new study, which are published in the British ...

A study has found that people with eczema are able to bathe either daily or weekly, without any impact on their symptoms. The findings of the new study, which are published in the British Journal of ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

If you or someone you love has ever dealt with frequent dry, red or itchy patches of skin, you likely know how frustrating eczema can be. The condition can impact confidence, comfort and daily routine ...